Assessment of leech therapy for knee osteoarthritis: a randomized study
Randomized controlled trial published in Acta Orthopaedica (2008)
Abstract
BACKGROUND AND PURPOSE: Symptomatic treatment of osteoarthritis of the knee with leeches is presently undergoing a renaissance. Previous studies have shown methodical weaknesses. In the present study patients were blinded regarding the treatment, and a control group was included to explore possible differences in various subjective clinical scores and intake of pain medication over time between leech therapy and placebo control. PATIENTS AND METHODS: 113 patients with advanced osteoarthritis of the knee were included. The patients were randomized to a single treatment group, group I (single leech application, n = 38), a double treatment group, group II (double application, n = 35), and a control group (n = 40). The second treatment in group II took place after an interval of 4 weeks. The treatment in the control group was simulated with the help of an "artificial leech". Results were documented with the KOOS and WOMAC scores and also a visual analog scale (VAS) for pain. Changes in the use of pain medication were monitored over 26 weeks. RESULTS: An improvement in KOOS and WOMAC scores, and also in VAS, was found in all 3 groups following treatment. These improvements were statistically significant for treatment groups I and II during the complete follow-up period. The reduction in individual requirements for pain medication was also statistically significant. The greatest improvement was seen in the group treated twice with the leeches, with a long-term reduction of joint stiffness and improved function in the activities of daily living. INTERPRETATION: Leech therapy can reduce symptoms caused by osteoarthritis. Repeated use of the leeches appears to improve the long-term results. We have not determined whether the positive outcome of the leech therapy is caused by active substances released during the leeching, the placebo effect, or the high expectations placed on this unusual treatment form.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Open RCT of 113 patients with symptomatic knee osteoarthritis comparing single leech application with topical diclofenac control. Leech group showed greater WOMAC pain reduction at 7 and 28 days. Treatment well tolerated.
Por qué esto importa para la hirudoterapia
Este ensayo controlado aleatorizado investigó aplicaciones únicas y dobles de sanguijuelas frente a un control con 'sanguijuela artificial' placebo en 113 pacientes con osteoartritis de rodilla avanzada. Ambos grupos de tratamiento con sanguijuelas mostraron mejoras estadísticamente significativas en las puntuaciones de KOOS, WOMAC y VAS, con una reducción del consumo de analgésicos durante un seguimiento de 26 semanas; el grupo de aplicación doble mostró la mayor mejora en rigidez y función articular. Los autores concluyen que la terapia con sanguijuelas puede reducir los síntomas de la osteoartritis, pero explícitamente declaran que no pudieron determinar si los resultados se debían a sustancias activas liberadas durante la aplicación de sanguijuelas, al efecto placebo o a las altas expectativas de los pacientes. Esta incertidumbre, reconocida por los propios autores, limita la fuerza de cualquier conclusión sobre el mecanismo terapéutico de la terapia con sanguijuelas.
Citación
Assessment of leech therapy for knee osteoarthritis: a randomized study.
Andereya S et al. · Acta orthopaedica, 2008
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026